• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT R TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT R TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVOLUTR-34
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem Insufficient Information (4580)
Event Date 04/19/2024
Event Type  Injury  
Manufacturer Narrative
Initial reporter details unavailable due regional privacy regulations.Select patient information cannot be included in the regulatory report due to regional privacy regulations.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received information that during implant of this transcatheter bioprosthetic valve, the valve was positioned correct and confirmed during the angiographic check.The valve was released and dislodged ventricular.The patient was sent to cardio surgery and the valve was explanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received that a pre-balloon aortic valvuloplasty (bav) was performed.After the valve was explanted, a su rgical valve was implanted.
 
Manufacturer Narrative
Image review: four static images were provided for review of the event.The patient¿s executive summary was not provided for anatomical review.It appears that the cusp overlap technique was used, however, depth assessment in the cusp overlap view was not provided for review.Just prior to the point of no recapture, depth assessment was performed in the left anterior oblique (lao) view and appeared to be approximately 8-9mm at the left-coronary cusp (lcc).In this case, proper depth assessment at the non-coronary cusp (ncc) was not confirmed, so depth at the ncc is unknown.Medtronic recommends a target depth of 3mm.Recapture is recommended if depth <(><<)>1mm or >5mm.Thus, a recapture was warranted.However, the valve was released and dislodged ventricular.It was reported that the patient was converted to surgery to explant the dislodged valve.Updated: d9, h3, h6 note: the returned device has been received, however, product analysis had not yet been completed.Results of the product analysis will be submitted upon analysis completion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT R TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19161191
MDR Text Key340794720
Report Number2025587-2024-02464
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 05/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/07/2024
Device Model NumberEVOLUTR-34
Device Catalogue NumberEVOLUTR-34
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/19/2024
Initial Date FDA Received04/23/2024
Supplement Dates Manufacturer Received04/23/2024
Not provided
Supplement Dates FDA Received04/25/2024
05/29/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-